Elsevier Inc.

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Scordo
    Scordo
  4. Shah
    Shah
  5. Ponce
    Ponce
  6. Dahi
    Dahi
  7. Papadopoulos
    Papadopoulos
  8. Jakubowski
    Jakubowski
  9. Devlin
    Devlin
  10. Castro-Malaspina
    Castro-Malaspina

Groups

  1. CTCR Scholars (390)
  2. Department of Medicine (348)
  3. Hematologic Malignancies, Division of (318)
  4. Center for Hematologic Malignancies (303)
  5. Bone Marrow Transplant (296)
  6. Survivorship Research (274)
  7. MSK Grad Students (225)
  8. Master of Science in Clinical and Translational Cancer Research (219)
  9. Epidemiology and Biostatistics (165)
  10. Biostatistics Service (162)
Search Within
  1. "CTCR Scholars"
Formats
  1. Meeting Abstract (252)
  2. Journal Article (110)
  3. Review (15)
  4. Guidelines (5)
  5. Book Section (3)
  6. Editorial (3)
  7. Correspondence (1)
  8. Research Letter (1)
Groups
  1. CTCR Scholars (390)
  2. Department of Medicine (348)
  3. Hematologic Malignancies, Division of (318)
  4. Center for Hematologic Malignancies (303)
  5. Bone Marrow Transplant (296)
  6. Survivorship Research (274)

More Groups

People
  1. Sergio Giralt (219)
  2. Miguel-Angel Perales (146)
  3. Michael Scordo (121)
  4. Sean Devlin (118)
  5. Gunjan Shah (114)
  6. Doris Ponce (108)

More People

Years
  1. 2025 (9)
  2. 2024 (36)
  3. 2023 (45)
  4. 2022 (56)
  5. 2021 (22)
  6. 2020 (59)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (187)
  2. Transplantation and Cellular Therapy (55)
  3. Gynecologic Oncology (50)
  4. Clinical Lymphoma, Myeloma and Leukemia (48)
  5. International Journal of Radiation Oncology, Biology, Physics (16)
  6. Journal of Thoracic Oncology (6)

More Publications

Results (390)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ipilimumab after CD34-selected allogeneic stem cell transplantation (Allo HCT) for patients with relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Ghosh, A.; Nagel, K.; Hosszu, K.; Datta, A.; Thompson, C.; Levia, K.; Kamrowski, A.; McAvoy, D.; Chung, D.; Landau, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Evolving M-spike and risk of progression in smoldering multiple myeloma
    Meeting Abstract

    Hultcrantz, M.; Nemirovsky, D.; Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Patel, D.; Shah, U.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Adding Plinabulin to pegfilgrastim to shorten neutropenia and improve quality of life peri-autologous hematopoietic cell transplant for multiple myeloma
    Meeting Abstract

    Shah, G.; Hanley, D.; Datta, A.; Kamrowski, A.; Chung, D.; Gupta, G.; Hassoun, H.; Hoover, E.; Hultcrantz, M.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Impact of absolute lymphocyte count at pre-apheresis and pre-lymphodepletion on chimeric antigen receptor (CAR)-T therapy outcomes in relapsed refractory multiple myeloma (RRMM)
    Meeting Abstract

    Nishimura, N.; Flynn, J.; Costa, B.; Devlin, S.; Farzana, T.; Nath, K.; Chung, D.; Landau, H.; Lahoud, O.; Scordo, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Vitamin D deficiency and clinical outcomes with chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma
    Meeting Abstract

    Nishimura, N.; Flynn, J.; Costa, B.; Devlin, S.; Farzana, T.; Chung, D.; Landau, H.; Lahoud, O.; Scordo, M.; Shah, G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Evaluating dynamic changes in the serum free light chain ratio and its effect on risk of progression in smoldering multiple myeloma
    Meeting Abstract

    Akhlaghi, T.; Nemirovsky, D.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Patel, D.; Shah, U.; Tan, C. R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Comprehensive genomic characterization of response and resistance to daratumumab based quadruplet induction in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Maclachlan, K.; Tan, C. R.; Shekarkhand, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; McPherson, A.; Diamond, B.; Blaney, P.; Ziccheddu, B.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Prognostic impact of corticosteroid and tocilizumab use on the efficacy of chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma
    Meeting Abstract

    Costa, B.; Flynn, J.; Nath, K.; Nishimura, N.; Devlin, S.; Farzana, T.; Chung, D.; Landau, H.; Lahoud, O.; Scordo, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Patterns of cytokine release syndrome with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy
    Meeting Abstract

    Hamadeh, I.; Shekarkhand, T.; Rueda, C.; Firestone, R.; Wang, A.; Korde, N.; Hultcrantz, M.; Lesokhin, A.; Mailankody, S.; Hassoun, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Bispecific T-cell engager response is driven by pre-treatment CD8+ effector memory cells and inhibited by TIGIT+ Tregs in relapsed/refractory multiple myeloma
    Meeting Abstract

    Firestone, R.; McAvoy, D.; Shekarkhand, T.; Serrano, E.; Hamadeh, I.; Wang, A.; Zhu, M.; Patel, D.; Tan, C. R.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save